Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 21, 2019
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
Anusha Pusuluri, Debra Wu, Samir Mitragotri
Bioengineering & Translational Medicine
|
January 30, 2018
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation
Douglas R Vogus, Anusha Pusuluri, Renwei Chen, et al.
Bioengineering & Translational Medicine
|
June 29, 2019
Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin
Anusha Pusuluri, Vinu Krishnan, Debra Wu, et al.
Pharmaceutics
|
January 20, 2021
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
Debra Wu, Douglas Vogus, Vinu Krishnan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 14, 2020
Design principles of drug combinations for chemotherapy
Debra Wu, Anusha Pusuluri, Douglas Vogus, et al.
Angewandte Chemie (International Ed. in English)
|
December 12, 2018
Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate
Anusha Pusuluri, Vinu Krishnan, Valerie Lensch, et al.
Nature Chemistry
|
May 25, 2017
Engineering live cell surfaces with functional polymers via cytocompatible controlled radical polymerization
Jia Niu, David J Lunn, Anusha Pusuluri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 2, 2016
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
Kathryn M Camacho, Stefano Menegatti, Douglas R Vogus, et al.
ACS Chemical Biology
|
September 19, 2019
Click-Particle Display for Base-Modified Aptamer Discovery
Chelsea K L Gordon, Diana Wu, Anusha Pusuluri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 22, 2017
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
Douglas R Vogus, Michael A Evans, Anusha Pusuluri, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 21, 2019
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
Anusha Pusuluri, Debra Wu, Samir Mitragotri
Bioengineering & Translational Medicine
|
January 30, 2018
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation
Douglas R Vogus, Anusha Pusuluri, Renwei Chen, et al.
Bioengineering & Translational Medicine
|
June 29, 2019
Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin
Anusha Pusuluri, Vinu Krishnan, Debra Wu, et al.
Pharmaceutics
|
January 20, 2021
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
Debra Wu, Douglas Vogus, Vinu Krishnan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 14, 2020
Design principles of drug combinations for chemotherapy
Debra Wu, Anusha Pusuluri, Douglas Vogus, et al.
Angewandte Chemie (International Ed. in English)
|
December 12, 2018
Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate
Anusha Pusuluri, Vinu Krishnan, Valerie Lensch, et al.
Nature Chemistry
|
May 25, 2017
Engineering live cell surfaces with functional polymers via cytocompatible controlled radical polymerization
Jia Niu, David J Lunn, Anusha Pusuluri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 2, 2016
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
Kathryn M Camacho, Stefano Menegatti, Douglas R Vogus, et al.
ACS Chemical Biology
|
September 19, 2019
Click-Particle Display for Base-Modified Aptamer Discovery
Chelsea K L Gordon, Diana Wu, Anusha Pusuluri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 22, 2017
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
Douglas R Vogus, Michael A Evans, Anusha Pusuluri, et al.
Page
of 2